Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-22

Clinical Trial Update: Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing misoprostol vs oxytocin infusion for reducing blood loss during abdominal myomectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MISOPROSTOL (Misoprostol)
  • oxytocin infusion (oxytocin)

Snippet

Sponsor: Cairo University | Conditions: Myoma;Uterus | Phase 3 | Status: UNKNOWN